US2011021637A1PendingUtilityA1

Xanthohumol and tetrahydro-isoalpha acid based protein kinase modulation cancer treatment

51
Assignee: METAPROTEOMICS LLCPriority: Jun 20, 2001Filed: Apr 6, 2010Published: Jan 27, 2011
Est. expiryJun 20, 2021(expired)· nominal 20-yr term from priority
A61K 36/53A61P 35/00A61K 31/12A61K 31/122A61K 36/3486
51
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Compounds and methods for protein kinase modulation for cancer treatment are disclosed. The compounds and methods disclosed are based on xanthohumol or isoxantohumol, or tetrahydro-isoalpha acids commonly found in hops.

Claims

exact text as granted — not AI-modified
1 . A composition to treat a cancer responsive to protein kinase modulation in a mammal in need thereof, said composition comprising a therapeutically effective amount of a chalcone and a tetrahydro-isoalpha acid (THIAA); wherein said therapeutically effective amount modulates a cancer associated protein kinase. 
     
     
         2 . The composition of  claim 1 , wherein the chalcone is xanthohumol or isoxanthohumol. 
     
     
         3 . The composition of  claim 1 , wherein the composition further comprises a pharmaceutically acceptable excipient selected from the group consisting of coatings, isotonic and absorption delaying agents, binders, adhesives, lubricants, disintergrants, coloring agents, flavoring agents, sweetening agents, absorbants, detergents, and emulsifying agents. 
     
     
         4 . The composition of  claim 1 , wherein the composition further comprises one or more members selected from the group consisting of antioxidants, vitamins, minerals, proteins, fats, and carbohydrates. 
     
     
         5 . The composition of  claim 1 , wherein the tetrahydro-isoalpha acid is selected from the group consisting of tetrahydro-isohumulone, tetrahydro-isocohumulone, and tetrahydro-adhumulone. 
     
     
         6 . The composition of  claim 1 , wherein the composition further comprises a pharmaceutically acceptable excipient selected from the group consisting of coatings, isotonic and absorption delaying agents, binders, adhesives, lubricants, disintergrants, coloring agents, flavoring agents, sweetening agents, absorbants, detergents, and emulsifying agents. 
     
     
         7 . The composition of  claim 1 , wherein the composition further comprises one or more members selected from the group consisting of antioxidants, vitamins, minerals, proteins, fats, and carbohydrates.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.